Role of surgical ventricular restoration post surgical treatment of heart failure (STICH) trial

  • Anjith Prakash RajakumarEmail author
  • Mithun Sundararaaja Ravikumar
  • Vijayanand Palanisamy
  • Karthik Raman
  • Anbarasu Mohanraj
  • Jacob Jamesraj
  • Valikapthalil Mathew Kurian
  • Mullasari Ajit
  • Rajan Sethuratnam
Original Article



To compare the outcomes of isolated coronary artery bypass grafting (CABG) versus surgical ventricular restoration (SVR) with or without CABG for patients with ischemic cardiomyopathy (ICM).


Retrospectively, 49 patients with ICM and severe LV dysfunction (LVEF < 35%) who underwent SVR with or without CABG from January 2009 to December 2016 at a single institution was compared with 49 patients who underwent isolated CABG. The two groups were matched for preoperative clinical and echocardiographic parameters including left ventricular end-diastolic diameter (LVIDd), left ventricular end-systolic diameter (LVIDs), left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume (LVEDV), and left ventricular end-systolic volume (LVESV). Primary outcomes analyzed included early mortality, late mortality, and major adverse cardiac or cerebrovascular events (MACCE). Secondary outcomes analyzed included echocardiographic parameters of left ventricular volume and function-indexed left ventricular end-diastolic volume (LVEDVi), indexed left ventricular end-systolic volume (LVESVi), and LVEF. Cox and survival analysis was performed.


Early and late mortality in SVR vs. CABG groups were 4 (8.1%) and 6 (12.2%) vs. 1 (2%) and 5 (10.2%) respectively. Mean improvement in LVEF was 3.39 ± 7.51 compared to 4.97 ± 5.45 between the two groups at 3-month follow-up. Mean improvement in LVEF was 5.1 ± 8.3 in the SVR group vs 5.9 ± 7.1 in the CABG group at the last follow-up. There was no statistically significant improvement between the two groups in terms of LVEF at 3 months or the last follow-up. There were statistically significant differences between LVEDVi and LVESVi between the two groups at 3 months and the last follow-up. The 5-year rates of survival were 85 ± 6 and 82 ± 9% for SVR and CABG groups respectively. The 5-year rates of freedom from MACCE were 75 ± 7 and 60 ± 11% for SVR and CABG groups respectively.


Compared with isolated CABG, SVR plus CABG results in equivalent late mortality and better left ventricular reverse remodeling (as evidenced by LV volume reduction) and better freedom from MACCE at 5-year follow-up.


Stich trial Dor’s ventriculoplasty MACCE 



We acknowledge the statistical analysis and support provided by Dr. Balaji, Assistant Professor, Department of Community Medicine, The Madras Medical College.

Presentation at meetings


Compliance with ethical standards

Institutional review board approval has been obtained for the publishing of patient profile and this article.

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human rights

For this type of study formal consent is not required.


  1. 1.
    Gheorghiade M, Bonow RO. Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation. 1998;97:282–9.CrossRefGoogle Scholar
  2. 2.
    Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360:1705–17.CrossRefGoogle Scholar
  3. 3.
    Buckberg GD, Coghlan HC, Torrent-Guasp F. The structure and function of the helical heart and its buttress wrapping.V. Anatomic and physiologic considerations in the healthy and failing heart. Semin Thorac Cardiovasc Surg. 2001;13:358–85.CrossRefGoogle Scholar
  4. 4.
    Buckberg G. Left ventricular reconstruction for dilated ischaemic cardiomyopathy: biology, registry, randomisation and credibility. Eur J Thorac Cardiovasc Surg. 2006;30:753–61.CrossRefGoogle Scholar
  5. 5.
    Cooley DA, Collins HA, Morris GC, Chapman DW. Ventricular aneurysm after myocardial infarction. Surgical excision with use of temporary cardiopulmonary bypass. JAMA. 1958;167:557.CrossRefGoogle Scholar
  6. 6.
    Jatene AD. Left ventricular aneurysmectomy. Resection or reconstruction. J Thorac Cardiovasc Surg. 1985;89:321–31.Google Scholar
  7. 7.
    Dor V, Kreitmann P, Jourdan J, et al. Interest of physiological closure (circumferential plasty on contractile areas) of left ventricle after resection and endocardiectomy for aneurysm or akinetic zone. Comparison with classical technique about a series of 209 left ventricular resections. J Cardiovasc Surg. 1985;26:73.Google Scholar
  8. 8.
    Mann DL, Bristow MR. Mechanisms and models in heart failure. The biomechanical model and beyond. Circulation. 2005;111:2837–49.CrossRefGoogle Scholar
  9. 9.
    Migrino RQ, Young JB, Ellis SG, et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. Circulation. 1997;96:116–21.CrossRefGoogle Scholar
  10. 10.
    Sutton MSJ, Pfeffer MA, Moye L, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction baseline predictors and impact of long-term use of captopril: Information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation. 1997;96:3294–9.CrossRefGoogle Scholar
  11. 11.
    Yamaguchi A, Ino T, Adachi H, et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg. 1998;65:434–8.CrossRefGoogle Scholar
  12. 12.
    Menicanti L, Castelvecchio S, Ranucci M, et al. Surgical therapy for ischemic heart failure: single center experience with surgical anterior ventricular restoration. J Thorac Cardiovasc Surg. 2007;134:433–41.CrossRefGoogle Scholar
  13. 13.
    Calafiore AM, Iaco AL, Kheirallah H, et al. Outcome of left ventricular surgical remodelling after the STICH trial. Eur J Cardiothorac Surg. 2016;50:694–702.CrossRefGoogle Scholar
  14. 14.
    Dor V, Civaia F, Alexandrescu C, Sabatier M, Montiglio F. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg. 2011;141:905–16.CrossRefGoogle Scholar
  15. 15.
    Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53.CrossRefGoogle Scholar
  16. 16.
    Götte MJ, Germans T, Rüssel IK, et al. Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging. studies in normal and impaired left ventricular function. J Am Coll Cardiol. 2006;48:2002–11.CrossRefGoogle Scholar
  17. 17.
    Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global Longitudinal Strain: A Novel Index of Left Ventricular Systolic Function. J Am Soc Echocardiogr. 2004;17:630–3.CrossRefGoogle Scholar
  18. 18.
    Artis NJ, Oxborough DL, Williams G, Pepper CB, Tan LB. Two-dimensional strain imaging: A new echocardiographic advance with research and clinical applications. Int J Cardiol. 2008;123:240–8.CrossRefGoogle Scholar
  19. 19.
    Buckberg GD, Athanasuleas CL. The STICH trial: misguided conclusions. J Thorac Cardiovasc Surg. 2009;138:1060–4.CrossRefGoogle Scholar
  20. 20.
    Dor V. Left ventricular reconstruction: the aim and the reality after twenty years. J Thorac Cardiovasc Surg. 2004;128:17–20.CrossRefGoogle Scholar
  21. 21.
    Athanasuleas CL, Buckberg GD, Stanley AW, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol. 2004;44:1439–45.CrossRefGoogle Scholar
  22. 22.
    Shah PJ, Hare DL, Raman JS, et al. Survival after myocardial revascularization for ischemic cardiomyopathy: a prospective ten-year follow-up study. J Thorac Cardiovasc Surg. 2003;126:1320–7.CrossRefGoogle Scholar

Copyright information

© Indian Association of Cardiovascular-Thoracic Surgeons 2018

Authors and Affiliations

  • Anjith Prakash Rajakumar
    • 1
    Email author
  • Mithun Sundararaaja Ravikumar
    • 1
  • Vijayanand Palanisamy
    • 1
  • Karthik Raman
    • 1
  • Anbarasu Mohanraj
    • 1
  • Jacob Jamesraj
    • 1
  • Valikapthalil Mathew Kurian
    • 1
  • Mullasari Ajit
    • 2
  • Rajan Sethuratnam
    • 1
  1. 1.Department of Cardiac SurgeryInstitute of Cardiovascular Diseases, The Madras Medical MissionChennaiIndia
  2. 2.Department of CardiologyInstitute of Cardiovascular Diseases, The Madras Medical MissionChennaiIndia

Personalised recommendations